Impact on HbA1c and body weight of switching from other GLP ‐1 receptor agonists to semaglutide: A model‐based approach

Diabetes, Obesity and Metabolism, EarlyView.

Source: Diabetes, Obesity and Metabolism - August 24, 2018 Category: Endocrinology Authors: Rune V. Overgaard PhD , S øren Ø. Lindberg MD , Desirée Thielke MD Source Type: research